DB14873InvestigationalGene Therapies
Enadenotucirev is under investigation in clinical trial NCT02636036 (Phase I Study of Enadenotucirev and PD-1 Inhibitor in Subjects With Metastatic or Advanced Epithelial Tumors).
Resolves to
Compound
What you can answer from here — as of April 23, 2025
Which companies are running trials of Enadenotucirev, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account